FDA Permits Marketing of Bio-Seal Lung Biopsy Tract Plug System
Reduces risk of collapsed lung following lung biopsy The U.S. Food and Drug Administration today...
Read More
Author: PWeekly
FDA Approves Raxibacumab to Treat Inhalational Anthrax
First monoclonal antibody approved using the Animal Efficacy Rule. The U.S. Food and Drug...
Read More
FDA Approves Orphan Drug Signifor for Cushing’s Disease
The U.S. Food and Drug Administration today approved Signifor (pasireotide diaspartate) injection...
Read More
FDA Approves Iclusig to Treat Two Rare Types of Leukemia
Drug approved 3 months ahead of schedule The U.S. Food and Drug Administration today approved...
Read More
FDA Expands Zytiga’s Use for Late-stage Prostate Cancer
Drug can now be used before treatment with chemotherapy The U.S. Food and Drug Administration...
Read More
FDA Approves Cometriq to Treat Rare Type of Thyroid Cancer
The U.S. Food and Drug Administration today approved Cometriq (cabozantinib) to treat medullary...
Read More
FDA Approves First Seasonal Influenza Vaccine Manufactured Using Cell Culture Technology
The U.S. Food and Drug Administration announced today the approval of Flucelvax, the first...
Read More
FDA Approves Pump for Heart Failure Patients Awaiting Heart Transplant
The U.S. Food and Drug Administration today approved the HeartWare Ventricular Assist System, a...
Read More
2012 VEITHsymposium: Pros and Cons of Multilayer Stent Technology to be Debated
Belgian Device Being Marketed in E.U., Still Awaiting U.S. Approval. The multilayer stent system...
Read More
2012 VEITHsymposium: New Medicines, New Technologies Provide Vascular Surgeons Expanded Options for Treatment of Pulmonary Embolism
Vascular specialists are heralding a variety of advances in the treatment of pulmonary embolism...
Read More
2012 VEITHsymposium: New Techniques and New Technologies in the Endovascular Arena
New techniques and endovascular technologies will be in the spotlight during the 39th annual...
Read More
2012 VEITHsymposium: Minimally Invasive Procedures for Aortic Aneurysm Repair
Experts Present New Stenting Techniques Using “Off the Shelf” Devices, Will Combine Good Outcomes...
Read More
2012 VEITHsymposium: Effective Endovascular Treatments of Ruptured Abdominal Aortic Aneurysms
Discussions on the Value and Necessity of Level 1 Evidence The treatment of abdominal aortic...
Read More
2012 VEITHsymposium: Long-Term Patency Rates With SFA Stents
The Particulars: Previous research has not established the success rate for stenting of the...
Read More
2012 VEITHsymposium: Controversial Surgical Treatment for Multiple Sclerosis
Chronic Cerebrovenous Insufficiency Remains a Diagnosis in Question. In 2010, Italian vascular...
Read More
FDA Approves First Drug-Eluting Stent to Treat Peripheral Arterial Disease
The U.S. Food and Drug Administration approved the Zilver PTX Drug-Eluting Peripheral Stent...
Read More
2012 VEITHsymposium: Simplifying Aortic Arch Repair
The Particulars: Among patients with an inadequate proximal landing zone and/or severe angles...
Read More
2012 VEITHsymposium: Analyzing Hybrid Treatment of Aortic Arch Aneurysms
The Particulars: Hybrid repair of aortic arch aneurysms—in which supra-aortic trunks are rerouted...
Read More
2012 VEITHsymposium: An Alternative for AAA Repair
The Particulars: Alternatives to open surgery for abdominal aortic aneurysms (AAAs) are needed...
Read More
2012 VEITHsymposium: Competing Treatments for Carotid Artery Disease
Exploring Best Medical Treatments vs. an Intervention The continuing debate among vascular...
Read More